These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 16289474
1. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Orlando F, Mocchegiani F, Silvestri C, Licci A, Chiodi L, Lukasiak J, Saba V, Scalise G. Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474 [Abstract] [Full Text] [Related]
3. Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. Giacometti A, Cirioni O, Ghiselli R, Orlando F, Silvestri C, Renzone G, Testa I, Mocchegiani F, Della Vittoria A, Saba V, Scaloni A, Scalise G. J Biomed Mater Res A; 2007 Apr; 81(1):233-9. PubMed ID: 17120214 [Abstract] [Full Text] [Related]
4. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G. Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078 [Abstract] [Full Text] [Related]
5. Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. Ghiselli R, Giacometti A, Cirioni O, Mocchegiani F, Silvestri C, Orlando F, Kamysz W, Licci A, Nadolski P, Della Vittoria A, Łukasiak J, Scalise G, Saba V. JPEN J Parenter Enteral Nutr; 2007 Oct; 31(6):463-8. PubMed ID: 17947600 [Abstract] [Full Text] [Related]
6. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Cirioni O, Giacometti A, Ghiselli R, Bergnach C, Orlando F, Mocchegiani F, Silvestri C, Licci A, Skerlavaj B, Zanetti M, Saba V, Scalise G. Peptides; 2006 Sep; 27(9):2104-10. PubMed ID: 16621147 [Abstract] [Full Text] [Related]
7. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin]. Kotulová D, Slobodníková L. Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169 [Abstract] [Full Text] [Related]
8. Model of Staphylococcus aureus central venous catheter-associated infection in rats. Ulphani JS, Rupp ME. Lab Anim Sci; 1999 Jun; 49(3):283-7. PubMed ID: 10403443 [Abstract] [Full Text] [Related]
9. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. Rose WE, Poppens PT. J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338 [Abstract] [Full Text] [Related]
10. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Chelliah A, Heydon KH, Zaoutis TE, Rettig SL, Dominguez TE, Lin R, Patil S, Feudtner C, St John KH, Bell LM, Coffin SE. Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377 [Abstract] [Full Text] [Related]
11. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489 [Abstract] [Full Text] [Related]
13. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection. Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Silvestri C, Orlando F, Mocchegiani F, Vittoria AD, Kamysz E, Saba V, Scalise G. Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542 [Abstract] [Full Text] [Related]
14. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. LaPlante KL, Mermel LA. Nephrol Dial Transplant; 2007 Aug; 22(8):2239-46. PubMed ID: 17403700 [Abstract] [Full Text] [Related]
15. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters. Aslam S, Darouiche RO. J Antimicrob Chemother; 2007 Jul; 60(1):148-51. PubMed ID: 17525051 [Abstract] [Full Text] [Related]
16. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. Lee MY, Ko KS, Song JH, Peck KR. J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978 [Abstract] [Full Text] [Related]
17. Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm. Aybar Y, Ozaras R, Besirli K, Engin E, Karabulut E, Salihoglu T, Mete B, Tabak F, Mert A, Tahan G, Yilmaz MH, Ozturk R. Int J Antimicrob Agents; 2012 Apr; 39(4):338-42. PubMed ID: 22364717 [Abstract] [Full Text] [Related]
18. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EA. J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696 [Abstract] [Full Text] [Related]
19. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment. Monzón M, García-Alvarez F, Laclériga A, Gracia E, Leiva J, Oteiza C, Amorena B. J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127 [Abstract] [Full Text] [Related]
20. In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance. Munson EL, Heard SO, Doern GV. Chest; 2004 Nov; 126(5):1628-35. PubMed ID: 15539737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]